Researcher discovers how new HIV vaccine candidate can control HIV progression
Tuesday, January 19, 2010 - 17:28
in Health & Medicine
(PhysOrg.com) -- Researchers from the University of Toronto and Mount Sinai Hospital have made significant findings about how a new HIV vaccine candidate (Delta 5) can reduce -- and in some cases stop -- HIV progression by triggering natural immunity.